Ralf Weber

Dr. Ralf Weber

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MVMark Viant
Mark Viant
TETimothy Ebbels
Timothy Ebbels
Richard BegerRichard Beger
Richard Beger
DEDrew R. Ekman
Drew R. Ekman
DEDavid J. T. Epps
David J. T. Epps
RWRalf Weber
Ralf Weber
Metabolomics is a widely used technology in academic research, yet its application to regulatory science has been limited. The most commonly cited barrier to its translation is lack of performance and reporting standards. The MEtabolomics standaRds Initiative in Toxicology (MERIT) project brings together international experts from multiple sectors to address this need. Here, we identify the most relevant applications for metabolomics in regulatory toxicology and develop best practice guidelines, performance and reporting standards for acquiring and analysing untargeted metabolomics and targeted metabolite data. We recommend that these guidelines are evaluated and implemented for several regulatory use cases.

23 September 2019 in Metabolites
Verified
Journal Article
Open access
PDF file
JSJan Stanstrup
Jan Stanstrup
CBCorey D. Broeckling
Corey D. Broeckling
RHRick Helmus
Rick Helmus
NHNils Hoffmann
Nils Hoffmann
Ewy MathéEwy Mathé
Ewy Mathé
Steffen NeumannSteffen Neumann
Steffen Neumann
Metabolomics aims to measure and characterise the complex composition of metabolites in a biological system. Metabolomics studies involve sophisticated analytical techniques such as mass spectrometry and nuclear magnetic resonance spectroscopy, and generate large amounts of high-dimensional and complex experimental data. Open source processing and analysis tools are of major interest in light of innovative, open and reproducible science. The scientific community has developed a wide range of open source software, providing freely available advanced processing and analysis approaches. The programming and statistics environment R has emerged as one of the most popular environments to process and analyse Metabolomics datasets. A major benefit of such an environment is the possibility of connecting different tools into more complex workflows. Combining reusable data processing R scripts with the experimental data thus allows for open, reproducible research. This review provides an extensive overview of existing packages in R for different steps in a typical computational metabolomics workflow, including data processing, biostatistics, metabolite annotation and identification, and biochemical network and pathway analysis. Multifunctional workflows, possible user interfaces and integration into workflow management systems are also reviewed. In total, this review summarises more than two hundred metabolomics specific packages primarily available on CRAN, Bioconductor and GitHub.

23 February 2016 in GigaScience
Verified
Journal Article
Open access
PDF file
RDRobert L Davidson
Robert L Davidson
RWRalf Weber
Ralf Weber
HLHaoyu Liu
Haoyu Liu
ASArchana Sharma-Oates
Archana Sharma-Oates
MVMark Viant
Mark Viant
Background: Metabolomics is increasingly recognized as an invaluable tool in the biological, medical and environmental sciences yet lags behind the methodological maturity of other omics fields. To achieve its full potential, including the integration of multiple omics modalities, the accessibility, standardization and reproducibility of computational metabolomics tools must be improved significantly. Results: Here we present our end-to-end mass spectrometry metabolomics workflow in the widely used platform, Galaxy. Named Galaxy-M, our workflow has been developed for both direct infusion mass spectrometry (DIMS) and liquid chromatography mass spectrometry (LC-MS) metabolomics. The range of tools presented spans from processing of raw data, e.g. peak picking and alignment, through data cleansing, e.g. missing value imputation, to preparation for statistical analysis, e.g. normalization and scaling, and principal components analysis (PCA) with associated statistical evaluation. We demonstrate the ease of using these Galaxy workflows via the analysis of DIMS and LC-MS datasets, and provide PCA scores and associated statistics to help other users to ensure that they can accurately repeat the processing and analysis of these two datasets. Galaxy and data are all provided pre-installed in a virtual machine (VM) that can be downloaded from the GigaDB repository. Additionally, source code, executables and installation instructions are available from GitHub. Conclusions: The Galaxy platform has enabled us to produce an easily accessible and reproducible computational metabolomics workflow. More tools could be added by the community to expand its functionality. We recommend that Galaxy-M workflow files are included within the supplementary information of publications, enabling metabolomics studies to achieve greater reproducibility.

27 December 2016 in Metabolomics
Verified
Journal Article
Open access
PDF file
RWRalf Weber
Ralf Weber
TLThomas N. Lawson
Thomas N. Lawson
Reza SalekReza Salek
Reza Salek
TETimothy Ebbels
Timothy Ebbels
RGRobert C. Glen
Robert C. Glen
MVMark Viant
Mark Viant

7 December 2018 in GigaScience
Verified
Journal Article
Open access
PDF file
Kristian PetersKristian Peters
Kristian Peters
JBJames Bradbury
James Bradbury
SBSven Bergmann
Sven Bergmann
MCMarco Capuccini
Marco Capuccini
MCMARTA CASCANTE
MARTA CASCANTE
CSChristoph Steinbeck
Christoph Steinbeck
Background: Metabolomics is the comprehensive study of a multitude of small molecules to gain insight into an organism's metabolism. The research field is dynamic and expanding with applications across biomedical, biotechnological, and many other applied biological domains. Its computationally intensive nature has driven requirements for open data formats, data repositories, and data analysis tools. However, the rapid progress has resulted in a mosaic of independent, and sometimes incompatible, analysis methods that are difficult to connect into a useful and complete data analysis solution. Findings: PhenoMeNal (Phenome and Metabolome aNalysis) is an advanced and complete solution to set up Infrastructure-as-a-Service (IaaS) that brings workflow-oriented, interoperable metabolomics data analysis platforms into the cloud. PhenoMeNal seamlessly integrates a wide array of existing open-source tools that are tested and packaged as Docker containers through the project's continuous integration process and deployed based on a kubernetes orchestration framework. It also provides a number of standardized, automated, and published analysis workflows in the user interfaces Galaxy, Jupyter, Luigi, and Pachyderm. Conclusions: PhenoMeNal constitutes a keystone solution in cloud e-infrastructures available for metabolomics. PhenoMeNal is a unique and complete solution for setting up cloud e-infrastructures through easy-to-use web interfaces that can be scaled to any custom public and private cloud environment. By harmonizing and automating software installation and configuration and through ready-to-use scientific workflow user interfaces, PhenoMeNal has succeeded in providing scientists with workflow-driven, reproducible, and shareable metabolomics data analysis platforms that are interfaced through standard data formats, representative datasets, versioned, and have been tested for reproducibility and interoperability. The elastic implementation of PhenoMeNal further allows easy adaptation of the infrastructure to other application areas and ‘omics research domains.

29 July 2020 in The Analyst
Verified
Journal Article
Open access
PDF file
ASAndrew Southam
Andrew Southam
LHLiam D. Haglington
Liam D. Haglington
Lukáš NajdekrLukáš Najdekr
Lukáš Najdekr
AJAndris Jankevics
Andris Jankevics
RWRalf Weber
Ralf Weber
WDWarwick Dunn
Warwick Dunn
In this study we assess multiple sample preparation methods for UHPLC-MS metabolic phenotyping analysis of human urine and plasma. All methods are discussed in terms of metabolite and lipid coverage and reproducibility.